Fidelity Select Biotechnology Portfolio (FBIOX)

Fund Assets	5.26B
Expense Ratio	0.63%
Min. Investment	$0.00
Turnover	38.00%
Dividend (ttm)	0.62
Dividend Yield	2.41%
Dividend Growth	171.18%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Dec 12, 2025

Previous Close	25.65
YTD Return	2.35%
1-Year Return	36.62%
5-Year Return	13.89%
52-Week Low	15.68
52-Week High	26.19
Beta (5Y)	0.59
Holdings	185
Inception Date	Dec 16, 1985

About FBIOX

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Average
• Risk Rating: Above Average
• Stock Exchange: NASDAQ
• Ticker Symbol: FBIOX
• Index: S&P 500 TR

Performance

FBIOX had a total return of 36.62% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.70%.

Top 10 Holdings

53.94% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	14.23%
Krystal Biotech, Inc.	KRYS	8.65%
Amgen Inc.	AMGN	7.20%
Gilead Sciences, Inc.	GILD	7.14%
Alnylam Pharmaceuticals, Inc.	ALNY	4.70%
Insmed Incorporated	INSM	2.92%
argenx SE	ARGX	2.61%
Ascendis Pharma A/S	ASND	2.32%
UCB SA	UCB	2.18%
Praxis Precision Medicines, Inc.	PRAX	1.98%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 12, 2025	$0.559	Dec 15, 2025
Apr 11, 2025	$0.062	Apr 14, 2025
Dec 13, 2024	$0.166	Dec 16, 2024
Apr 12, 2024	$0.063	Apr 15, 2024
Dec 27, 2023	$0.002	Dec 28, 2023
Dec 1, 2023	$0.078	Dec 4, 2023